This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NOI - Dynamic Genome: CHIP
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health, Office of the Director, Office of Acquisitions, intends to award a firm-fixed-price purchase order without full and open competition to Vanderbilt University Medical Center for specialized computational analysis services to identify clonal hematopoiesis of indeterminate potential (CHIP) in longitudinal whole genome sequencing datasets from the Framingham Heart Study. This solicitation, numbered 75N98026Q00362, is issued as a Notice of Intent under FAR Part 12.603 as a streamlined commercial item acquisition, leveraging statutory authority under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) to justify non-competitive award based on the necessity for continuity with the incumbent vendor. The work involves recalibrating historical sequencing data collected over a decade, detecting somatic mutations using validated bioinformatics pipelines, and ensuring reproducibility across timepoints to support research into age-related heart, lung, and blood diseases. Performance is to be conducted at Vanderbilt’s facility in Nashville, Tennessee, with all data accessed remotely via NIH-managed platforms dbGaP and TOPMed Data Exchange, under strict human subject data security protocols prohibiting local storage or transfer of raw genomic data. The contract has a defined period of performance from June 1, 2026, to September 30, 2026, with an incorporated option under FAR 52.217-8 to extend services subject to funding and mutual agreement. Evaluation will be based on non-price factors including past performance, methodological consistency, and capability to maintain continuity with prior analytical workflows, as the government prioritizes reproducibility over cost minimization. Proposals must be submitted electronically by May 29, 2026, to Nicholas Capobianco at NIH, and must include evidence of valid SAM.gov registration, Unique Entity Identifier, Taxpayer Identification Number, and demonstrated expertise in CHIP analysis and longitudinal whole genome sequencing. Invoicing must be submitted exclusively through the Department of Treasury’s Invoice Processing Platform and copied to NHLBIContractsBranchB@mail.nih.gov. The government retains responsibility for inspection and acceptance, with quality control limited to gender matching and verification against known control samples. No packaging, marking, or DPAS requirements apply, and the solicitation does not include set-asides, though offerors must self-certify their size status under NAICS code 541990. All contract clauses are incorporated by
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
(ii) The solicitation number is 75N98026Q00362 and the solicitation is issued as a Notice of Intent (NOI) of a non-competitive (notice of intent) combined synopsis solicitation to award a contract or purchase order without providing for full or open competition (including brand-name).
This acquisition is conducted under the authority of the FAR Part 12.603¿ Streamlined solicitation for commercial products or commercial services, and is not expected to exceed the simplified acquisition threshold, and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii).
The National Institutes of Health, Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order without providing for full and open competition (Including brand-name) to Vanderbilt University Medical Center
1161 21st Ave S, Suite D3300 MCN Nashville, TN 37232-0001 for specialized computational analysis services to identify clonal hematopoiesis of indeterminate potential (CHIP) in longitudinal whole genome sequencing datasets.
This requirement is a follow-on effort to previously completed work performed by the same vendor. Continuation with the same source is necessary to maintain methodological consistency across longitudinal datasets, ensure reproducibility of prior analyses, and avoid duplication of cost and schedule delays associated with revalidation of analytical pipelines.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
